ORIC
Oric Pharmaceuticals Inc
13.30$
-1.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.3% | -0.8% | +4.2% | -0.7% | +12.6% | -0.7% | +2.6% | -7.1% | +11.1% | -15.6% | -2.2% | – | |
| – | +1.5% | +26.4% | +0.8% | +1.2% | +2.9% | +26.0% | +0.3% | -14.3% | +11.5% | +9.9% | +2.8% | – | |
| – | -45.4% | -511.6% | – | -29.0% | +83.3% | -293.7% | – | – | -22.4% | -340.4% | – | – | |
| – | -26.0% | +282.5% | +52.8% | +25.5% | -47.6% | +76.7% | -83.7% | -44.4% | +1,005.7% | -99.5% | +17,700.0% | – | |
| – | – | -395.1% | – | +26.2% | +84.9% | -47.4% | -442.7% | +43.7% | – | -205.8% | – | – | |
| – | -299.8% | – | – | -200.0% | – | – | – | – | – | – | – | – | |
| – | +1,361.3% | +27,537.5% | -99.3% | -84.6% | +356.3% | -56.0% | +52,983.8% | -18.5% | -98.6% | +3,976.0% | -98.6% | – | |
| – | – | – | -119.8% | – | – | -166.4% | – | -198.7% | – | – | -276.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.